Corient Capital Partners’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,721
Closed -$427K 469
2019
Q3
$427K Sell
13,721
-834
-6% -$25.4K 0.06% 285
2019
Q2
$508K Sell
14,555
-2,492
-15% -$80.6K 0.08% 233
2019
Q1
$500K Buy
+17,047
New +$483K 0.08% 219
2018
Q4
Sell
-25,582
Closed -$900K 300
2018
Q3
$900K Hold
25,582
0.15% 150
2018
Q2
$1.05M Buy
25,582
+3,452
+16% +$139K 0.18% 143
2018
Q1
$867K Buy
22,130
+8,520
+63% +$312K 0.16% 137
2017
Q4
$444K Sell
13,610
-3,009
-18% -$104K 0.08% 198
2017
Q3
$794K Buy
+16,619
New +$810K 0.15% 139

Other funds holding ACHC

Corient Capital Partners's ACHC Position: Q4 2019 in Review

Corient Capital Partners sold out of Acadia Healthcare (ACHC) in Q4 2019, closing a stake of 13,721 shares — an estimated $427K sold.

Corient Capital Partners first reported a position in ACHC in Q3 2017 and held it in 8 quarters. The position peaked at $1.05M in Q2 2018. 244 funds tracked by Wall St. Rank hold ACHC as of Q4 2019.

  • Corient Capital Partners reported no remaining Acadia Healthcare position as of Q4 2019 after selling out during the quarter.
  • Corient Capital Partners sold 13,721 Acadia Healthcare shares in Q4 2019, an estimated $427K.
  • Corient Capital Partners first reported a position in Acadia Healthcare in Q3 2017 and held it in 8 quarters.
  • Corient Capital Partners's Acadia Healthcare position peaked at $1.05M in Q2 2018.
  • 244 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2019.

Based on Corient Capital Partners's 13F filing for Q4 2019, filed 4 Feb 2020.